GB1460348A - Quinazoline derivativesa - Google Patents

Quinazoline derivativesa

Info

Publication number
GB1460348A
GB1460348A GB501574A GB501574A GB1460348A GB 1460348 A GB1460348 A GB 1460348A GB 501574 A GB501574 A GB 501574A GB 501574 A GB501574 A GB 501574A GB 1460348 A GB1460348 A GB 1460348A
Authority
GB
United Kingdom
Prior art keywords
derivativesa
quinazoline
oxyphenbutazone
probenecid
chloroquine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB501574A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB501574A priority Critical patent/GB1460348A/en
Priority to ZA00750134A priority patent/ZA75134B/xx
Priority to AU77240/75A priority patent/AU7724075A/en
Priority to BE153011A priority patent/BE825128R/xx
Priority to FR7503262A priority patent/FR2259613A2/fr
Publication of GB1460348A publication Critical patent/GB1460348A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB501574A 1974-02-04 1974-02-04 Quinazoline derivativesa Expired GB1460348A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB501574A GB1460348A (en) 1974-02-04 1974-02-04 Quinazoline derivativesa
ZA00750134A ZA75134B (en) 1974-02-04 1975-01-07 Quinazoline derivatives
AU77240/75A AU7724075A (en) 1974-02-04 1975-01-10 Quinazoline derivatives
BE153011A BE825128R (fr) 1974-02-04 1975-02-03 Derives de l'indole
FR7503262A FR2259613A2 (enExample) 1974-02-04 1975-02-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB501574A GB1460348A (en) 1974-02-04 1974-02-04 Quinazoline derivativesa

Publications (1)

Publication Number Publication Date
GB1460348A true GB1460348A (en) 1977-01-06

Family

ID=9788143

Family Applications (1)

Application Number Title Priority Date Filing Date
GB501574A Expired GB1460348A (en) 1974-02-04 1974-02-04 Quinazoline derivativesa

Country Status (5)

Country Link
AU (1) AU7724075A (enExample)
BE (1) BE825128R (enExample)
FR (1) FR2259613A2 (enExample)
GB (1) GB1460348A (enExample)
ZA (1) ZA75134B (enExample)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003066046A1 (en) * 2002-02-05 2003-08-14 Astrazeneca Ab Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
EP2060258A1 (en) 2003-10-23 2009-05-20 Oxagen Limited Use of CRTH2 antagonist compounds in therapy
WO2009090414A1 (en) 2008-01-18 2009-07-23 Oxagen Limited Compounds having crth2 antagonist activity
WO2009093026A1 (en) 2008-01-22 2009-07-30 Oxagen Limited Compounds having crth2 antagonist activity
US8168673B2 (en) 2008-01-22 2012-05-01 Oxagen Limited Compounds having CRTH2 antagonist activity
EP2492268A1 (en) 2006-07-22 2012-08-29 Oxagen Limited Compounds having CRTH2 antagonist activity
US9828359B2 (en) 2013-12-17 2017-11-28 Atopix Therapeutics Limited Process for the preparation of 3-substituted (indol-1-yl)-acetic acid esters

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003066046A1 (en) * 2002-02-05 2003-08-14 Astrazeneca Ab Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
EP2060258A1 (en) 2003-10-23 2009-05-20 Oxagen Limited Use of CRTH2 antagonist compounds in therapy
US7582672B2 (en) 2003-10-23 2009-09-01 Oxagen Limited Compounds for the treatment of CRTH2-mediated diseases and conditions
US8163936B2 (en) 2003-10-23 2012-04-24 Oxagen Limited Treatment of CRTH2-mediated diseases and conditions
US8163931B2 (en) 2003-10-23 2012-04-24 Oxagen Limited Treatment of CRTH2-mediated diseases and conditions
US8198314B2 (en) 2003-10-23 2012-06-12 Oxagen Limited Treatment of CRTH2-mediated diseases and conditions
US8314257B2 (en) 2003-10-23 2012-11-20 Oxagen Limited Treatment of CRTH2-mediated diseases and conditions
EP2492268A1 (en) 2006-07-22 2012-08-29 Oxagen Limited Compounds having CRTH2 antagonist activity
WO2009090414A1 (en) 2008-01-18 2009-07-23 Oxagen Limited Compounds having crth2 antagonist activity
WO2009093026A1 (en) 2008-01-22 2009-07-30 Oxagen Limited Compounds having crth2 antagonist activity
US8168673B2 (en) 2008-01-22 2012-05-01 Oxagen Limited Compounds having CRTH2 antagonist activity
US9828359B2 (en) 2013-12-17 2017-11-28 Atopix Therapeutics Limited Process for the preparation of 3-substituted (indol-1-yl)-acetic acid esters

Also Published As

Publication number Publication date
ZA75134B (en) 1976-01-28
AU7724075A (en) 1976-07-15
BE825128R (fr) 1975-08-04
FR2259613A2 (enExample) 1975-08-29

Similar Documents

Publication Publication Date Title
IE37998B1 (en) Indole derivatives
ES8106513A1 (es) Procedimiento para la preparacion de sales de la (+)-cate- quina
GB1460348A (en) Quinazoline derivativesa
AU2727984A (en) Imidazole-ethanol and esters thereof
GB1503675A (en) Compositions based on pyrimidine derivatives and their use in the treatment of viral infections
GB1528723A (en) 1-nitro-9-n-substituted aminoalkylamino-acridines their salts and a method of preparing same
IE34744L (en) Biphenyl crotonic acids.
GB1347433A (en) Acetophenone oxime derivatives and pharmaceutical preparations which contain the same
IT1168008B (it) Imidazol-eteri ed ester, procedimenti per prepararli e composizioni farmaceutiche che li contengono
GB1427114A (en) Derivatives of 3- p-chlorobenoyl-2-methyl-phenylacetic acid
DE3660403D1 (en) Derivative of acetylsalicylic acid, its preparation and pharmaceutical compositions containing it
GB1359560A (en) Preparation of pyrrylsalicylic acid
GB1154454A (en) New Anthranilic Acid Derivatives
GB1172864A (en) Aluminium-Containing Chelates
GB1113802A (en) Improvements in or relating to substituted quinolines and the manufacture thereof
JPS5764639A (en) Novel stilbene derivative, its preparation, and medical composition containing the same as active ingredent
ES8705860A1 (es) Procedimiento de preparacion de derivados de 3-hidroxi-3-fenilpiperidina
IE34139B1 (en) 4-phenyl-butric acid derivatives
GB1050565A (enExample)
ES430198A1 (es) Procedimiento para la preparacion de n-(heteroarilmetil - delta7-desoxi-normorfinas y -norcodeinas.
GB1223875A (en) Phenylbutazone derivatives
GB1252993A (enExample)
GB1239266A (enExample)
JPS57176958A (en) 1-(2',6'-dichlorophenyl)-2-methylthioindole and its preparation
GB1477263A (en) Thiamindisulphidemono-orotate and process for its preparation

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee